Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 1,440 | 2,500 | 5,690 | 3,630 |
| TOTAL | $N/A | $1,440 | $2,500 | $5,690 | $3,630 |
| Non-Current Assets | |||||
| PPE Net | N/A | 300 | 300 | N/A | 620 |
| Other Non-Current Assets | 0 | 2,620 | 2,600 | 4,030 | 4,040 |
| TOTAL | $N/A | $2,920 | $2,900 | $4,030 | $4,660 |
| Total Assets | $N/A | $4,360 | $5,400 | $9,720 | $8,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 920 | 620 | 0 | 1,690 |
| Accrued Expenses | N/A | 3,050 | 5,570 | N/A | 10,040 |
| Other current liabilities | N/A | 720 | 1,370 | N/A | 580 |
| TOTAL | $N/A | $4,730 | $7,600 | $N/A | $12,370 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 240 | 3 |
| TOTAL | $N/A | $110 | $119 | $240 | $253 |
| Total Liabilities | $N/A | $4,840 | $7,719 | $240 | $12,623 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 30 | 30 | N/A | 30 |
| Other shareholders' equity | 0 | 60 | 180 | 0 | 190 |
| TOTAL | $N/A | $230,910 | $230,770 | $N/A | $230,540 |
| Total Liabilities And Equity | $0 | $235,750 | $238,489 | $240 | $243,163 |